Kim HS, Yoo TK, Park WC, Chae BJ, et al. The prognostic value of HER2 status and efficacy of anti-HER2 therapy in patients with HR-positive mucinous breast cancer: a nationwide study from the Korean Breast Cancer Society. Breast Cancer Res Treat 2020 Feb 4. pii: 10.1007/s10549-020-05550.
PMID: 32020434